Summary

Cell Therapy Packaging Market, Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Therapy Packed (T-cell therapies, dendritic cell vaccines, stem cell therapies, NK-Cell therapies and other ATMPs), Package Engineering Design (primary and secondary packaging), Scale of Operation (clinical and commercial) and Key Geographical Regions (North America, Europe, Asia Pacific and Rest of the World)
Report Link: https://www.rootsanalysis.com/reports/cell-therapy-packaging-market.html

The Cell Therapy Packaging Market is expected to reach USD 361 million anticipated to grow at a CAGR of 11.8% during the forecast period 2024-2035.

Cell therapy entails the utilization of a patient's own cells (autologous) or the cells sourced from a healthy donor (allogeneic), which are genetically reprogrammed to combat various diseases. Patients receive injections of viable cells anticipated to offer therapeutic benefits. Notably, both cell and gene therapies have been employed to address a spectrum of rare and genetic medical conditions, encompassing cancer, arthritis, dementia, leukemia, and other challenging ailments. Currently, over 30 cell and gene therapies have secured FDA approvals, with numerous therapeutic candidates progressing through clinical development stages. In recent years, cell therapy has attracted significant attention from stakeholders in the healthcare industry, driven by its substantial potential in treating rare disorders. This is reinforced by a robust body of clinical evidence showcasing its therapeutic benefits and potential.

The effectiveness of cell therapies relies on the safe and timely delivery of viable therapeutic cell doses to suitable patients. Additionally, maintaining specific temperature conditions (dependent on the therapy) throughout the supply chain is vital to safeguarding the stability and integrity of cell therapy drug products. These therapies undergo rigorous regulatory scrutiny at each manufacturing stage to ensure adherence to packaging product quality standards. Given the intricacies involved in the cell therapy packaging landscape, numerous drug developers are opting to outsource their packaging requirements to Contract Research Organizations (CROs). Fueled by the escalating demand for cell-based therapeutics, the market for cell therapy packaging services is primed to experience substantial growth in the foreseeable future.

Research Coverage:
A thorough examination of the current market landscape of cell therapy packaging services providers, including a detailed analysis based on their year of establishment, company size, location of headquarters, type of services offered (packaging, distribution, storage, labeling, manufacturing, management solutions, drug return & destruction, serialization, analytical and other services), type of packaging (active and passive packaging), type of passive system offered (dry shippers and VIP insulations), packaging engineering design (primary and secondary packaging), phase change material used (dry ice and liquid nitrogen).
Comprehensive assessment of the current market landscape of cell therapy packaging products, providing information on type of packaging container (bag, vial, shipping container and others), type of container fabrication material (plastic and others), raw materials for container fabrication (ethylene vinyl acetate (EVA), insulated panel, polypropylene, fluorinated ethylene propylene, USP class VI materials, polyethylene and others), type of cells packed (blood cells, hematopoietic cells, lymphocytes, stem cells, mesenchymal cells, cord blood cells, induced pluripotent cells and chondrocytes), storage conditions (ambient, refrigerated, freezing and cryogenic temperatures), and usability of container (single-use and multiple-use products). Further, the product providers have also been analyzed on the basis of parameters, such as their year of establishment, company size, location of headquarters and most active players (in terms of number of products).
Comprehensive profiles of leading players (shortlisted based on a proprietary criterion) in offering cell therapy packaging products and services. Each profile features a brief overview of the company, details related to its service portfolio / product portfolio, recent developments and an informed future outlook.
An in-depth competitiveness assessment of cell therapy packaging service providers based across different geographies, by taking into consideration the service strength of a company (based on its experience), packaging portfolio (package engineering design, type of packaging, type of packaging material and temperature ranges supported), service portfolio (type of additional services offered).
Elaborative assessment of the different partnerships established between cell therapy packaging providers and cell therapy developers, during the period 2016-2021. It includes a brief description of various types of partnership models (namely service alliance, technology / platform integration agreement, merger and acquisition) adopted by stakeholders in this domain. It is worth mentioning that the data captured during our research was analyzed based on several parameters, such as year of partnership, type of partnership, purpose of partnership, type of service offered, and geographical location of players involved in the partnership.
A list of more than 250 cell therapy developers anticipated to partner with cell therapy packaging providers, which have been shortlisted on the basis of developer strength (based on company size), type of therapy and pipeline maturity (based on stage of development of drug candidate).
A case study highlighting the players, claiming to have the required expertise and capabilities for development and manufacturing of cell therapies, along with the information on their year of establishment, company size, location of headquarters and location of manufacturing facility. In addition, the chapter presents analysis on type of cells manufactured, source of cells, scale of operation and manufacturing capabilities / services of the aforementioned companies.
Exhaustive cell therapy packaging market forecast to estimate the current market size and future opportunity over the next 11 years. Based on multiple parameters, likely adoption of cell therapy packaging products and services and through secondary sources, we have provided an informed estimate on the market size during the forecast period 2024-2035.
Detailed projections of the current and future opportunity within the cell therapy packaging market across different type of therapies packed, such as T-cell therapies, dendritic cell vaccines, stem cell therapies, NK-cell therapies and other advanced therapy medicinal products.
Comprehensive predictions of the current and future opportunity within the cell therapy packaging market based on different scales of operations, such as clinical and commercial.
Elaborate predictions of the current and future cell therapy packaging market based on different package engineering designs, such as primary packaging and secondary packaging.
Comprehensive predictions of the current and future opportunity within the cell therapy packaging market based on key geographical regions, such as North America, Europe, Asia-Pacific and Rest of the World.
Key Benefits of Buying this Report
The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
The report provides stakeholders with a pulse on the Cell Therapy Packaging Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.
Leading Market Companies
Almac
Catalent Biologics
Cryoport Systems
Saint-Gobain
Thermo Fisher Scientific
West Pharmaceuticals
Yourway

ページTOPに戻る

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Pharmaceutical Filling and Packaging
3.3. Importance of Pharmaceutical Packaging
3.4. Types of Pharmaceutical Packaging

3.5. Packaging of Cell Therapies
3.5.1. Primary Packaging
3.5.2. Secondary Packaging

3.6. Cell Therapy Packaging: Key Considerations
3.7. Challenges associated with Cell Therapy Packaging
3.8. Concluding Remarks

4. CELL THERAPY PACKAGING SERVICE PROVIDERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Cell Therapy Packaging Service Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Services Offered
4.2.5. Analysis by Type of Packaging
4.2.6. Analysis by Type of Passive System Offered
4.2.7. Analysis by Type of Package Engineering Design
4.2.8. Analysis by Phase Change Material Used
4.2.9. Analysis by Temperature Ranges Supported
4.2.10. Analysis by Type of Cells Handled

5. CELL THERAPY PACKAGING PRODUCT PROVIDERS: MARKET LANDSCAPE
5.1. Chapter Overview
5.2. Cell Therapy Packaging Products: Market Landscape
5.2.1. Analysis by Type of Packaging Container
5.2.2. Analysis by Container Fabrication Material and Raw Materials for Container Fabrication
5.2.3. Analysis by Type of Cells Packed
5.2.4. Analysis by Storage Conditions
5.2.5. Analysis by Usability of Container

5.3. Cell Therapy Packaging: Product Providers Landscape
5.3.1. Analysis by Year of Establishment
5.3.2. Analysis by Company Size
5.3.3. Analysis by Location of Headquarters
5.3.4. Most Active Players: Distribution by Number of Products

6. CELL THERAPY PACKAGING SERVICE AND PRODUCT PROVIDERS: COMPANY PROFILES
6.1. Chapter Overview
6.2 Cell Therapy Packaging Service Providers
6.2.1. Almac
6.2.1.1. Company Overview
6.2.1.2. Cell Therapy Service Portfolio
6.2.1.3. Recent Developments and Future Outlook

6.2.2. Catalent Biologics
6.2.2.1. Company Overview
6.2.2.2. Cell Therapy Service Portfolio
6.2.2.3. Recent Developments and Future Outlook

6.2.3. Cryoport Systems
6.2.3.1. Company Overview
6.2.3.2. Cell Therapy Service Portfolio
6.2.3.3. Recent Developments and Future Outlook

6.2.4. Yourway
6.2.4.1. Company Overview
6.2.4.2. Cell Therapy Service Portfolio
6.2.4.3. Recent Developments and Future Outlook

6.3. Cell Therapy Packaging Product Providers
6.3.1. Saint-Gobain Life Sciences
6.3.1.1. Company Overview
6.3.1.2. Cell Therapy Packaging Product Portfolio
6.3.1.3. Recent Developments and Future Outlook

6.3.2. Thermo Fisher Scientific
6.3.2.1. Company Overview
6.3.2.2. Cell Therapy Packaging Product Portfolio
6.3.2.3. Recent Developments and Future Outlook

6.3.3. West Pharmaceutical Services
6.3.3.1. Company Overview
6.3.3.2. Cell Therapy Packaging Product Portfolio
6.3.3.3. Recent Developments and Future Outlook

7. COMPANY COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Key Parameters
7.3. Methodology
7.4. Cell Therapy Packaging Service Providers: Company Competitiveness Analysis
7.4.1. Companies based in North America
7.4.2. Companies based in Europe and Asia-Pacific

8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Cell Therapy Packaging: List of Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year and Type of Partnership
8.3.4. Analysis by Purpose of Partnership
8.3.5. Analysis by Type of Service(s) Covered
8.3.6. Most Active Players: Analysis by Number of Partnerships
8.3.7. Regional Analysis
8.3.8. Intercontinental and Intracontinental Agreements

9. LIKELY PARTNER ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Potential Strategic Partners for Cell Therapy Packaging Providers in North America
9.3.1. Most Likely Partners
9.3.2. Likely Partners
9.3.3. Less Likely Partners

9.4. Potential Strategic Partners for Cell Therapy Packaging Providers in Europe
9.4.1. Most Likely Partners
9.4.2. Likely Partners
9.4.3. Less Likely Partners

9.5. Potential Strategic Partners for Cell Therapy Packaging Providers in Asia Pacific and Rest of the World
9.5.1. Most Likely Partners
9.5.2. Likely Partners
9.5.3. Less Likely Partners

10. CELL THERAPY DEVELOPERS AND MANUFACTURERS: CASE STUDY
10.1. Chapter Overview
10.2. Cell Therapy Manufacturers: Overall Market Landscape
10.2.1. Analysis by Year of Establishment
10.2.2. Analysis by Company Size
10.2.3. Analysis by Location of Headquarters
10.2.4. Analysis by Location of Manufacturing Facility
10.2.5. Analysis by Type of Cell(s) Manufactured
10.2.6. Analysis by Source of Cells
10.2.7. Analysis by Scale of Operation
10.2.8. Analysis by Manufacturing Capabilities / Services
10.2.9. Concluding Remarks

11. GLOBAL CELL THERAPY PACKAGING MARKET
11.1. Chapter Overview
11.2. Assumptions and Methodology
11.3. Global Cell Therapy Packaging Services Market, Forecasted Estimates (2024-2035)
11.4. Scenario Analysis
11.4.1. Conservative Scenario
11.4.2. Optimistic Scenario

11.5. Key Market Segmentations

12. CELL THERAPY PACKAGING MARKET, BY TYPE OF THERAPY
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Cell Therapy Packaging Market: Distribution by Type of Therapy
12.3.1. T-cell Therapies Packaging: Forecasted Estimates (2024-2035)
12.3.2. Dendritic Cell Vaccines Packaging: Forecasted Estimates (2024-2035)
12.3.3. Stem Cell Therapies Packaging: Forecasted Estimates (2024-2035)
12.3.4. NK-Cell Therapies Packaging: Forecasted Estimates (2024-2035)
12.3.5. Other Advanced Therapy Medicinal Products Packaging: Forecasted Estimates (2024-2035)

12.4. Data Triangulation and Validation

13. CELL THERAPY PACKAGING MARKET, BY SCALE OF OPERATION
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Cell Therapy Packaging Market: Distribution by Scale of Operation
13.3.1. Clinical Scale: Forecasted Estimates (2024-2035)
13.3.2. Commercial Scale: Forecasted Estimates (2024-2035)

13.4. Data Triangulation and Validation

14. CELL THERAPY PACKAGING MARKET, BY PACKAGE ENGINEERING DESIGN
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Cell Therapy Packaging Market: Distribution by Package Engineering Design
14.3.1. Primary Packaging: Forecasted Estimates (2024-2035)
14.3.2. Secondary Packaging: Forecasted Estimates (2024-2035)

14.4. Data Triangulation and Validation

15. CELL THERAPY PACKAGING MARKET, BY KEY GEOGRAPHICAL REGIONS
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Cell Therapy Packaging Market: Distribution by Key Geographical Regions
15.3.1. North America: Forecasted Estimates (2024-2035)
15.3.2. Europe: Forecasted Estimates (2024-2035)
15.3.3. Asia-Pacific: Forecasted Estimates (2024-2035)
15.3.4. Rest of the World: Forecasted Estimates (2024-2035)

15.4. Data Triangulation and Validation

16. CONCLUDING REMARKS
16.1. Chapter Overview

17. APPENDIX 1: TABULATED DATA

18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

ページTOPに戻る

List of Tables/Graphs

Figure 2.1 Executive Summary: Service Providers Landscape
Figure 2.2 Executive Summary: Product Providers Landscape
Figure 2.3 Executive Summary: Partnerships and Collaborations
Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Traditional Aseptic Pharmaceutical Filling
Figure 3.2 Advantages of Pharmaceutical Packaging
Figure 3.3 Types of Pharmaceutical Packaging
Figure 3.4 Packaging Containers for Cell Therapies
Figure 3.5 Challenging aspects of Cell Therapy Packaging
Figure 4.1 Cell Therapy Packaging Service Providers: Distribution by Year of Establishment
Figure 4.2 Cell Therapy Packaging Service Providers: Distribution by Company Size
Figure 4.3 Cell Therapy Packaging Service Providers: Distribution by Location of Headquarters
Figure 4.4 Cell Therapy Packaging Service Providers: Distribution by Company Size and Location of Headquarters
Figure 4.5 Cell Therapy Packaging Service Providers: Distribution by Services Offered
Figure 4.6 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging
Figure 4.7 Cell Therapy Packaging Service Providers: Distribution by Passive System Used
Figure 4.8 Cell Therapy Packaging Service Providers: Distribution by Package Engineering Design
Figure 4.9 Cell Therapy Packaging Service Providers: Distribution by Type of Phase Change Material
Figure 4.10 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging and Phase Change Material
Figure 4.11 Cell Therapy Packaging Service Providers: Distribution by Temperature Ranges Supported
Figure 4.12 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging, Packaging Material and Temperature Ranges Supported
Figure 4.13 Cell Therapy Packaging Service Providers: Distribution by Type of Cells Handled
Figure 5.1 Cell Therapy Packaging Products: Distribution by Type of Packaging Container
Figure 5.2 Cell Therapy Packaging Products: Distribution by Container Fabrication Material and Raw Materials for Container Fabrication
Figure 5.3 Cell Therapy Packaging Products: Distribution by Type of Packaging and Type of Container Fabrication Material
Figure 5.4 Cell Therapy Packaging Products: Distribution by Type of Cells Packed
Figure 5.5 Cell Therapy Packaging Products: Distribution by Storage Temperature
Figure 5.6 Cell Therapy Packaging Products: Distribution by Usability of Container
Figure 5.7 Cell Therapy Packaging Product Providers: Distribution by Year of Establishment
Figure 5.8 Cell Therapy Packaging Product Providers: Distribution by Company Size
Figure 5.9 Cell Therapy Packaging Product Providers: Distribution by Location of Headquarters
Figure 5.10 Cell Therapy Packaging Product Providers: Distribution by Company Size and Location of Headquarters
Figure 5.11 Key Cell Therapy Packaging Product Providers: Distribution by Number of Products
Figure 6.1 Almac: Cell Therapy Service Portfolio
Figure 6.2 Catalent Biologics: Cell Therapy Service Portfolio
Figure 6.3 Cryoport Systems: Cell Therapy Service Portfolio
Figure 6.4 Yourway: Cell Therapy Service Portfolio
Figure 7.1 Company Competitiveness Analysis: Cell Therapy Packaging Service Providers based in North America
Figure 7.2 Company Competitiveness Analysis: Cell Therapy Packaging Service Providers based in Europe and Asia-Pacific
Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2016-2021
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2016-2021 (till April)
Figure 8.4 Partnerships and Collaborations: Distribution by Purpose of Partnership
Figure 8.5 Partnerships and Collaborations: Distribution by Type of Service(s) Covered
Figure 8.6 Most Active Players: Distribution by Number of Partnerships
Figure 8.7 Partnerships and Collaborations: Distribution by Location of Parent Company
Figure 8.8 Partnerships and Collaborations: Distribution by Location of Partner Company
Figure 8.9 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 10.1 Cell Therapy Manufacturers: Distribution by Year of Establishment
Figure 10.2 Cell Therapy Manufacturers: Distribution by Company Size
Figure 10.3 Cell Therapy Manufacturers: Distribution by Location of Headquarters
Figure 10.4 Cell Therapy Manufacturers: Distribution by Location of Headquarters (Country Wise)
Figure 10.5 Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Region-wise)
Figure 10.6 Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Country-wise)
Figure 10.7 Cell Therapy Manufacturers: Distribution by Type of Cells Manufactured
Figure 10.8 Cell Therapy Manufacturers: Distribution by Type of Manufacturers
Figure 10.9 Cell Therapy Manufacturers: Distribution by Source of Cells
Figure 10.10 Cell Therapy Manufacturers: Distribution by Scale of Operation
Figure 10.11 Cell Therapy Manufacturers: Distribution by Manufacturing Capabilities / Services
Figure 11.1 Global Cell Therapy Packaging Market, Forecasted Estimates (2024-2035) (USD Million)
Figure 11.2 Global Cell therapy Packaging Market, Forecasted Estimates (2024-2035), Conservative Scenario (USD Million)
Figure 11.3 Global Cell therapy Packaging Market, Forecasted Estimates (2024-2035), Optimistic Scenario (USD Million)
Figure 12.1 Cell Therapy Packaging Market: Distribution by Type of Therapy, 2024 and 2035 (USD Million)
Figure 12.2 Cell Therapy Packaging Market for T-cell Therapies Packaging, Forecasted Estimates (2024-2035) (USD Million)
Figure 12.3 Cell Therapy Packaging Market for Dendritic Cell Vaccines Packaging, Forecasted Estimates (2024-2035) (USD Million)
Figure 12.4 Cell Therapy Packaging Market for Stem Cell Therapies Packaging, Forecasted Estimates (2024-2035) (USD Million)
Figure 12.5 Cell Therapy Packaging Market for NK-Cell Therapies Packaging, Forecasted Estimates (2024-2035) (USD Million)
Figure 12.6 Cell Therapy Packaging Market for Other Advanced Therapy Medicinal Products Packaging, Forecasted Estimates (2024-2035) (USD Million)
Figure 13.1 Cell Therapy Packaging Market: Distribution by Scale of Operation, 2024 and 2035 (USD Million)
Figure 13.2 Cell Therapy Packaging Market for Clinical Scale, Forecasted Estimates (2024-2035) (USD Million)
Figure 13.3 Cell Therapy Packaging Market for Commercial Scale, Forecasted Estimates (2024-2035) (USD Million)
Figure 14.1 Cell Therapy Packaging Market: Distribution by Package Engineering Design, 2024 and 2035 (USD Million)
Figure 14.2 Cell Therapy Packaging Market for Primary Packaging, Forecasted Estimates (2024-2035) (USD Million)
Figure 14.3 Cell Therapy Packaging Market for Secondary Packaging, Forecasted Estimates (2024-2035) (USD Million)
Figure 15.1 Cell Therapy Packaging Market: Distribution by Key Geographical Regions, 2024 and 2035 (USD Million)
Figure 15.2 Cell Therapy Packaging Market in North America, Forecasted Estimates (2024-2035) (USD Million)
Figure 15.3 Cell Therapy Packaging Market in Europe, Forecasted Estimates (2024-2035) (USD Million)
Figure 15.4 Cell Therapy Packaging Market in Asia-Pacific, Forecasted Estimates (2024-2035) (USD Million)
Figure 15.5 Cell Therapy Packaging Market in Rest of The World, Forecasted Estimates (2024-2035) (USD Million)
Figure 16.1 Concluding Remarks: Overall Service Providers Landscape
Figure 16.2 Concluding Remarks: Overall Products Landscape
Figure 16.3 Concluding Remarks: Partnerships and Collaborations
Figure 16.4 Concluding Remarks: Likely Partner Analysis
Figure 16.5 Concluding Remarks: Market Forecast